v3.26.1
Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Company's Restricted Stock Activity
A summary of INNOVATE’s restricted stock and restricted stock unit activity is as follows:
Number of Shares
Weighted-Average Grant Date Fair Value
Unvested - December 31, 2024294,663 $8.12 
Granted278,389 $5.90 
Vested(246,355)$8.05 
Forfeited(12,521)$7.99 
Unvested - December 31, 2025314,176 $6.22 
Schedule of Company's Stock Option Activity
A summary of INNOVATE’s stock option activity is as follows:
Number of Stock Options
Weighted-Average Exercise Price
Outstanding - December 31, 2024217,733 $16.94 
Granted
100,000$5.67 
Outstanding - December 31, 2025
317,733 $13.39 
Exercisable - December 31, 2024
117,733 $27.74 
Exercisable - December 31, 2025
217,733 $16.94 
Schedule of Stock Option Valuation Assumptions
The fair value of each stock option award was determined on the date of grant using the Black-Scholes option-pricing model using the following assumptions:

Year Ended December 31,
20252024
Stock price at date of grant
$4.75$6.27
Expected term
5.5 years
5.1 years -5.6 years
Risk-free interest rate
3.7 %4.1 %
Expected volatility
88.4 %
80.9% -82.7%
Expected dividend yield
— %— %
Grant date fair value per option
$3.34
$2.67 -$4.75